| |
|
|
|
Antares Pharma Inc.  
|
|
4.15 0.09 (0.02%) |
03-05 16:00 |
|
Open: |
4.1 |
Pre close: |
4.06 |
Target:
|
5.39 
|
|
High: |
4.16 |
Low: |
3.8857 |
Resistance:
|
4.62
5.07
|
|
Volume: |
2,157,579 |
Market Cap: |
698M |
Support:
|
3.89
3.23
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.21
|
MACD |
MACD(12,26):
|
-0.05 |
|
MA(20): |
4.52 |
Signal(12,26,9): |
0.03 |
|
MA(100): |
3.74  |
Stochastic Oscillator |
%K(14,3):
|
18.85 |
|
MA(250): |
3.14 |
%D(3): |
17.53 |
|
Average Volume(K) |
3-Month: |
146933
|
52-Week |
High:
|
5.07 |
|
10-Days: |
207013 |
Low: |
1.60 |
|
RSI |
RSI(14):
|
43.26 |
Change(%): |
33.9 |
|
Financials, Statistics and Valuation |
|
EPS |
0.330 |
Return on Equity (ttm) |
64.7 |
Shares Out. (M) |
168.16 |
|
EPS Est. Current Year |
-0.100 |
Return on Assets (ttm) |
4.9 |
Shares Float (M) |
156.09 |
|
EPS Est. Next Year |
0.010 |
PEG Ratio |
0.00 |
% Held by Insiders |
7.49 |
|
EPS Est. Next Quarter |
-0.030 |
Qtrly Rev. Growth |
16.6 |
% Held by Institutions |
43.95 |
|
Forward EPS |
-0.010 |
Gross Profit (p.s.) |
0.514 |
Shares Short (K) |
3920 |
|
Book Value (p.s.) |
0.710 |
EBITDA (p.s.) |
0.097 |
P/E |
12.58 |
|
Sales Per Share |
0.890 |
Qtrly Earnings Growth |
994.50 |
P/BV |
5.85 |
|
Profit Margin |
37.57 |
Operating Cash Flow
(M) |
21.32 |
P/S |
4.66 |
|
Operating Margin |
9.10 |
Levered Free Cash Flow
(M) |
5.98 |
P/CF |
32.73 |
|
|
|
|
|
|
